GET THE APP

Cold air plasma - A systemic selective adaptogen | 59593
International Journal of Biomedical Data Mining

International Journal of Biomedical Data Mining
Open Access

ISSN: 2090-4924

Cold air plasma - A systemic selective adaptogen


2nd International conference on Immunity and Immunochemistry

August 09, 2021 | WEBINAR

Deborah Black*, Mark Edwards, Keryn Johnson, Kostya (Ken) Ostrikov, Erik (Rik) Thompson

Bionic Air Pty Ltd , Gold Coast, Queensland, Australia
Asia Pacific Cell Technology, New South Wales Australia
Quantum Technologies Limited , Wellington, New Zealand Faculty of Science, Queensland
University & Technology , Brisbane Queensland Australia Faculty of Health, Queensland
University & Technology , Brisbane Queensland Australia

Scientific Tracks Abstracts: Int J Biomed Data Min

Abstract :

This mature plasma medicine device uses corona like cold air plasma technology, which has been designed for safe domestic and hospital use. It is the only one of its kind globally, first invented in 1967 by Australian Citizen Scientist Mr Joshua Shaw and enhanced by his protégé Deborah Black. Pulsed electrical fields of reactive and non-reactive, neutral and negatively charged air ion species are emitted through proprietary quantum portals with variable dosages of power and controlled frequencies which are fully regulated according to the health condition, and other variable factors of the patient for systemic biological benefits. Vibrating emissions and the proprietary safe electrical and magnetic fields created, primarily interact with the respiratory system enhancing immune responses of phagocytes, ameliorating the REDOX biology of the body and neurohormonal disturbances in a naturally selective manner, whilst working as a ‘systematic selective adaptogen®’ for the entire human body systems. The device has also been used for chronic wound healing in diabetic feet plus breast and other cancers. The special air species are both ingestible and transdermal. In Australia, this medical device is TGA registered and has had a long successful market history, reputation and process of Research & Development in humans over 53 years. It is medically registered in Australia and the UK for the treatment and prevention of virus, bacteria and other pathogen related respiratory conditions including colds and flu, allergies, hormones, chronic fatigue, depression, immune system recovery, assist medicine and vitamin absorption plus an array of additional medically allowable claims. Claims which were registered upon the support of safe results, no adverse health events and no recalls in human use. The purpose of this presentation is to show the many and varied impressive and safe results achieved in over 1 Million humans, in an effort to increase global collaboration efforts and scientific knowledge of its unique active mechanisms with modern science for the benefits of all humanity.

Biography :

Debbie is a recognised World Expert in Corona Cold Air Plasma Medicine with Quantum Physics and Ruach energy for biological benefits across the systems of the human body. She owns the patent for advancing the sciences of her medical device, now known as a “systemic selective adaptogen” and has an extensive record of results in humans across alot of medical conditions. 97% of her patients report they ‘no longer suffer colds and flu’. She has almost 10 years’ experience as an Independent Scientist working across 38 multidisciplinary scientific fields; 16 years of academic training and a 38-year career as a Chief Executive across 17 countries with 9.5 years in Fortune 100 companies including International diplomacy. She recognises Mr Joshua Shaw (1938-2019) the original inventor and her mentor for his life’s work and passion towards human health. She calls herself a ‘humanitarian on a mission to improve global health.’

Top